AVAILABLE NOW β€” EAST COAST AUSTRALIA & REMOTE

Australia's Specialist in
Aseptic Fill-Finish
& Sterile Manufacturing

15+ years delivering Annex 1 compliance, CQV programs, and sterile manufacturing projects across Europe and Australia. I solve the problems that keep your QP awake at night.

πŸ›οΈ ABN 46 730 540 268
βœ… EU GMP Annex 1 SME
πŸ›‘οΈ Fully Insured (PI & PL)
πŸ“Š Lean Six Sigma Green Belt
SCROLL
15+
YEARS EXPERIENCE
20+
PROJECTS DELIVERED
€1M+
COST SAVINGS
3
COUNTRIES
6
REGULATORY BODIES
WHAT I DELIVER

Specialist Services

Focused exclusively on sterile manufacturing and aseptic fill-finish. Not a generalist. Not a staffing agency. A named expert with 15 years of hands-on delivery.

πŸ§ͺ

Aseptic Fill-Finish

End-to-end expertise in sterile vial, syringe, and cartridge filling. Isolator CCS design, PUPSIT, media fills, and contamination control strategies aligned with EU GMP Annex 1 (2022).

πŸ“‹

EU GMP Annex 1 Compliance

Gap assessments, CCS documentation, and remediation roadmaps for the 2022 Annex 1 revision. Practical implementation β€” not just gap reports.

βš™οΈ

CQV & Validation

Commissioning, Qualification, and Validation for sterile manufacturing equipment, utilities, and facilities. VMP to Summary Report, risk-based approach.

🏭

Greenfield & Brownfield Projects

Project leadership for new sterile manufacturing facilities and major upgrades. URS, DQ, IQ, OQ, PQ, and handover to operations.

πŸ”¬

Process Engineering

Sterile process development, technology transfer, and scale-up. Lyophilisation, liquid filling, WFI systems, and cleanroom HVAC design review.

πŸ“Š

Regulatory & Audit Support

TGA, FDA, EMA, and ANVISA inspection readiness. Mock audits, CAPA management, and regulatory submission support for sterile products.

SPECIALIST EXPERTISE

EU GMP Annex 1 (2022)
Contamination Control Strategy

The 2022 Annex 1 revision is the most significant change to sterile manufacturing regulation in a generation. Most sites are still catching up. I have authored CCS documents, led isolator qualification programs, and implemented PUPSIT and environmental monitoring upgrades that satisfy TGA, EMA, and FDA expectations simultaneously.

β†’Contamination Control Strategy (CCS) authorship
β†’Isolator and RABS qualification (SKAN, Getinge, IMA)
β†’PUPSIT implementation and validation
β†’Environmental monitoring program design
β†’Media fill program development
REGULATORY BODIES
TGA Β· EMA Β· FDA Β· ANVISA Β· ICH Q10 Β· PIC/S
EQUIPMENT EXPERTISE
Isolators, RABS, Lyophilisers, Filling Lines, WFI Systems
CURRENT PROJECT
BACE II β€” Major aseptic fill-finish capital project, CSL Behring Melbourne
AVAILABILITY
Immediately available β€” East Coast AU, Remote, Europe
ABOUT

Gregor Gantar

Principal Process Engineer Β· Aseptic Fill-Finish SME Β· APG Pharm

I am a Principal Process Engineer with over 15 years of hands-on experience in sterile pharmaceutical manufacturing. My career spans Slovenia, Switzerland, and Australia β€” working with global leaders including Sandoz/Lek, Novartis TechOps, Lonza, SKAN AG, and CSL Behring.

My specialisation is aseptic fill-finish: isolator qualification, contamination control strategy, CQV program leadership, and regulatory compliance across TGA, EMA, FDA, and ANVISA. I have authored CCS documents from scratch, led complex capital projects, and delivered over €1M in process improvements.

I founded APG Pharm to bring this depth of expertise directly to Australian and European manufacturers who need a named specialist β€” not a staffing agency β€” to solve their most complex sterile manufacturing challenges.

B.Sc. Electrical Engineering β€” University of Ljubljana
Lean Six Sigma Green Belt
EU GMP Annex 1 CCS Specialist
TGA & FDA Inspection Ready
ABN 46 730 540 268
CAREER HISTORY

15 Years of Delivery

2011–2015Β·Slovenia

Process Engineer

Sandoz / Lek d.d.

Sterile manufacturing process development and validation for injectable products.

2015–2021Β·Slovenia

Senior Process Engineer

Novartis TechOps

Led CQV programs for aseptic fill-finish lines. Annex 1 compliance projects, isolator qualification, and process improvements delivering €1M+ in savings.

2021–2022Β·Switzerland

CQV Consultant

Lonza AG

Delivered CQV for sterile API and drug product manufacturing facilities.

2022Β·Switzerland

Validation Consultant

SKAN AG

Isolator and RABS qualification specialist for sterile fill-finish equipment.

2022Β·Switzerland

Process Engineering Consultant

ATP CG Pharm Group

Pharmaceutical engineering consulting for sterile manufacturing projects.

2022–PresentΒ·Melbourne, Australia

Principal Process Engineer

CSL Behring

Lead engineer on BACE II β€” a major aseptic fill-finish capital project. Annex 1 CCS authorship, isolator qualification, and cross-functional project leadership.

HOW WE WORK TOGETHER

Engagement Models

πŸ“…

Day Rate Contract

AUD 1,400–1,800/day

Short to medium-term contracts embedded in your team. Minimum 1 month.

πŸ“Œ

Fixed-Scope Project

Fixed price agreed upfront

Defined deliverables with clear milestones. Ideal for CCS, VMP, gap assessments.

🀝

Retained Advisory

Monthly retainer

Ongoing expert access for regulatory questions, audit prep, and technical reviews.

Payment Terms: Net 30 days (Net 60 available)
Invoicing via APG Pharm Β· ABN 46 730 540 268 Β· Professional Indemnity & Public Liability insured
Request a Proposal β†’
GET IN TOUCH

Let's Talk About
Your Project

I respond to all enquiries within 4 hours during business hours. For urgent matters, WhatsApp is the fastest route.

Send a Project Brief

This opens your email client. Alternatively, WhatsApp or call directly above.

AP
APG Pharm

Specialist aseptic fill-finish and sterile manufacturing consulting. Australia and Europe.

ABN 46 730 540 268 Β· Sole Trader trading as APG Pharm
SERVICES
Aseptic Fill-Finish
Annex 1 Compliance
CQV & Validation
Project Leadership
Regulatory Support
Β© 2025 APG Pharm Β· Gregor Gantar Β· All rights reserved
Talk to Gregor:WhatsApp AUWhatsApp EUβœ‰ Email